GB696405A - Improvements in or relating to preparations for muscular and nervous disorders and method of preparing the same - Google Patents
Improvements in or relating to preparations for muscular and nervous disorders and method of preparing the sameInfo
- Publication number
- GB696405A GB696405A GB28132/51A GB2813251A GB696405A GB 696405 A GB696405 A GB 696405A GB 28132/51 A GB28132/51 A GB 28132/51A GB 2813251 A GB2813251 A GB 2813251A GB 696405 A GB696405 A GB 696405A
- Authority
- GB
- United Kingdom
- Prior art keywords
- muscular
- preparations
- relating
- preparing
- nervous disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
A preparation for oral administration in muscular and nervous disorders comprises glycocyamine (HN=CNH2NHCH2COOH) and at least an equal molar quantity, per mol of glycocyamine, of a methylating agent (acting in vivo) selected from choline, betaine, betaine hydrate or dimethylthetine. It is preferred to use 1 1/2 to 5 mols of the methylating agent per mol glycocyamine. The preparation may be in the form of pellets or an aqueous suspension.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US696405XA | 1950-12-15 | 1950-12-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB696405A true GB696405A (en) | 1953-08-26 |
Family
ID=22090273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB28132/51A Expired GB696405A (en) | 1950-12-15 | 1951-11-30 | Improvements in or relating to preparations for muscular and nervous disorders and method of preparing the same |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB696405A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004000042A2 (en) * | 2002-06-19 | 2003-12-31 | N.V. Nutricia | Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
WO2004000297A1 (en) * | 2002-06-19 | 2003-12-31 | N.V. Nutricia | Nutritional or pharmaceutical compositions for increasing the creatine response of organisms |
-
1951
- 1951-11-30 GB GB28132/51A patent/GB696405A/en not_active Expired
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004000042A2 (en) * | 2002-06-19 | 2003-12-31 | N.V. Nutricia | Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
WO2004000297A1 (en) * | 2002-06-19 | 2003-12-31 | N.V. Nutricia | Nutritional or pharmaceutical compositions for increasing the creatine response of organisms |
WO2004000042A3 (en) * | 2002-06-19 | 2004-05-06 | Nutricia Nv | Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
EP2283835A3 (en) * | 2002-06-19 | 2011-12-28 | N.V. Nutricia | Method and preparation for treating metabolic stress |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3271829D1 (en) | An allergen dry powder composition and process for its preparation | |
GB1378348A (en) | Orally administered drug composition for therapy in the treatment of narcotic drug addiction | |
GB824908A (en) | Improvements in or relating to triazine derivatives | |
GB696405A (en) | Improvements in or relating to preparations for muscular and nervous disorders and method of preparing the same | |
ES427079A1 (en) | Phenothiazine derivatives, compositions thereof and methods of preparation thereof | |
JPS5441320A (en) | Slow release preparation and its manufacturing | |
ES453632A1 (en) | Alpha-Amino ketone derivatives | |
EP0030023A3 (en) | A heterocyclic compound and its synthesis, pharmaceutical formulations thereof and the use of the compounds and the formulations in medicine | |
Russell et al. | Evaluation of diammonium phosphate as a source of nitrogen for ruminants | |
GB1084152A (en) | ||
GB1505525A (en) | Pyridopyrimidines | |
GB1520248A (en) | Sodium cromoglycate containing medicament | |
FR2329260A1 (en) | Licking block for administering curative doses of medicaments - esp. anthelmintics, contains organoleptic agents such as sodium chloride and mineral salts | |
USD147266S (en) | Design for a brooch | |
GB1339467A (en) | Coccidiostatic compositions | |
ES393894A1 (en) | Piperidinemethyl ethers | |
USD157031S (en) | Col-ton combined camisole and slip | |
USD147843S (en) | Design for a toothbrush holder | |
GB1060069A (en) | Improvements in or relating to phenylethanolamines | |
GB1339636A (en) | Pharmaceutical compositions for inducing skeletal muscle relaxation | |
USD147942S (en) | Design for a bedstead | |
Nishiwaki et al. | Researches of Pot Spinning Machine, III | |
GB713720A (en) | Improvements in or relating to the preparation of stabilized liquid catalase | |
GB962889A (en) | New salts of n-(5-nitrofurfurylidene)-1-aminohydantoin | |
GB1330993A (en) | Mixture of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinsons disease |